Skip to main content

Market Overview

Morning Market Movers

Share:

Prosensa Holding NV (NASDAQ: RNA) shares climbed 62.28% to $18.57 after BioMarin Pharmaceutical (NASDAQ: BMRN) announced its plans to acquire Prosensa for $17.75 per share.

Cimatron (NASDAQ: CIMT) shares jumped 43.46% to $8.72 after 3D Systems (NYSE: DDD) announced its plans to acquire Cimatron for $8.97 per share.

Platinum Underwriters Holdings (NYSE: PTP) shares gained 19.24% to $73.06 after the company agreed to be acquired by RenaissanceRe Holdings (NYSE: RNR) for $76 per share.

Tetraphase Pharmaceuticals (NASDAQ: TTPH) shares climbed 13.17% to $25.00 According to Bloomberg, Tetraphase Pharma is exploring a sale option after being approached by potential buyers, people familiar with the matter said.

Synthetic Biologics (NYSE: SYN) rose 7.88% to $1.58 after the company reported that it is safe-to-proceed under IND to initiate clinical trials of SYN-004 for the prevention C. difficile infection.

Regulus Therapeutics (NASDAQ: RGLS) surged 6.78% to $17.33. Deutsche Bank initiated coverage on Regulus Therapeutics with a Buy rating and a $30.00 price target.

Sarepta Therapeutics (NASDAQ: SRPT) shares rose 5.85% to $16.65 after BioMarin Pharmaceutical announced its plans to acquire Prosensa for $17.75 per share.

China Ming Yang Wind Power Group (NYSE: MY) rose 5.21% to $2.83 after the company reported Q3 earnings of $0.09 per share on revenue of $279.70 million.

Geron (NASDAQ: GERN) shares rose 4.86% to $3.88 after surging 13.85% on Friday.

Ariad Pharmaceuticals (NASDAQ: ARIA) gained 4.45% to $6.81 after the company announced the marketing approval of Iclusig (ponatinib) in Australia.

 

Related Articles (BMRN + RNA)

View Comments and Join the Discussion!

Posted-In: market moversNews Intraday Update Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com